You are here:Home-Chemical Inhibitors & Agonists-Epigenetics-Bromodomain-XS018661
XS018661

Chemical Structure : XS018661

CAS No.: 878415-59-9

XS018661 (XS 018661)

Catalog No.: PC-20181Not For Human Use, Lab Use Only.

XS018661 (XS 018661) is a potent first-in-class inhibitor of the YEATS domains of ENL and AF9 with Kd of 754/523 nM, IC50 of 1.6/3.0 uM, respectively.

Packing Price Stock Quantity
25 mg Get quote
100 mg Get quote
250 mg Get quote
1 g Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC)

Biological Activity

XS018661 (XS 018661) is a potent first-in-class inhibitor of the YEATS domains of ENL and AF9 with Kd of 754/523 nM, IC50 of 1.6/3.0 uM, respectively.
XS018661 showed no significant inhibition below 20 µM for a number of bromodomains (BRD4[first domain], BRD9, CECR2, CREBBP, FALZ, TAF1, and BAZ2B) at 20 uM.
XS018661 demonstrate moderate cellular target engagement of XS018661 against AF9 in the micromolar range.
A mutant of AF9 with a deficiency in the binding pocket (Y78A) was not significantly affected by XS018661.

Physicochemical Properties

M.Wt 392.46
Formula C22H24N4O3
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

methyl 4-((2-(piperidin-1-ylmethyl)-1H-benzo[d]imidazol-5-yl)carbamoyl)benzoate

References

1. Christott T, et al. SLAS Discov. 2019 Feb;24(2):133-141.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: